Asthma is a chronic disease that affects many people. Approximately 155 million people suffer from asthma worldwide. In the case of intractable disease, sales of asthma medications in the pharmaceutical industry are nearly $ 5.5 billion. Asthma is an airway inflammatory disease. The airway narrows due to inflammation and excessive mucus secretion. Airway contractions cause common asthma symptoms such as wheezing, coughing, chest tightness and shortness of breath.
The asthma treatment guideline is based on asthma based on daytime asthma symptoms, nighttime asthma symptoms, use of emergency medicine, asthma to daily life, oral steroid use, and respiratory examination (spirometry) in the clinic Categorize into various categories. Asthma classification includes mild intermittent asthma, mild persistent asthma, moderate persistent asthma, and severe persistent asthma. Patients classified as having mild intermittent asthma usually require only short-acting emergency medicines. Inhaled corticosteroids are recommended for first-line treatment of mild persistent asthma using leukotriene modulators, theophylline or cromolyn as an alternative to inhaled corticosteroids
Anyone diagnosed with asthma is a candidate for asthma medicine. Patients with mild and uncommon asthma symptoms need only use short-acting emergency medications such as salbutamol (Bentrin HFA, Proventil-HFA, Vospearar ER, Pro Air HFA, Pro Air, Respic Click) There are cases. Patients with more frequent and persistent asthma symptoms are candidates for daily medication. The choice of drug depends on the severity of asthma. Regulated medicine is a daily medicine used to prevent or ameliorate asthma symptoms in patients with symptoms frequently. Whether to use regulated medications for asthma patients depends on the frequency and type of symptoms at day and night in clinics, the frequency of asthma treatment required, the frequency of oral corticosteroid use, the effect of asthma symptoms on asthma, daily life and respiratory tract examination Depends on. Run